
SDIC Venture Capital
Description
SDIC Venture Capital is a prominent state-backed venture capital firm based in Beijing, China, established by the State Development and Investment Corporation (SDIC). As a key player in China's strategic investment landscape, the firm is mandated to support and foster the growth of high-tech and emerging industries that align with national development priorities. Its investment strategy is deeply integrated with China's long-term economic and industrial upgrading goals, aiming to guide social capital into critical sectors.
The firm primarily focuses on strategic emerging industries, including advanced manufacturing, new generation information technology, biotechnology, new energy, new materials, and high-end equipment. SDIC Venture Capital manages multiple funds, notably the National Emerging Industry Venture Capital Guidance Fund, which was established with a substantial initial capital of approximately 40 billion RMB (around $5.5 billion USD). This significant capital base allows the firm to make substantial investments and play a leading role in large funding rounds.
SDIC Venture Capital typically invests in growth and late-stage companies, often participating in Series B, C, and later rounds. Their investments are characterized by a long-term perspective, aiming to support companies through various stages of development until they achieve market leadership or successful exits. The firm has built an extensive portfolio, with public databases indicating over 200 investments across various strategic sectors, underscoring its active role in shaping China's innovation ecosystem.
Investor Profile
SDIC Venture Capital has backed more than 28 startups, with 18 new investments in the last 12 months alone. The firm has led 16 rounds, about 57% of its total and boasts 9 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series A, Series Unknown rounds (top funding stages).
- Majority of deals are located in China, United States.
- Strong thematic focus on Manufacturing, Biotechnology, Pharmaceutical.
- Led 13 rounds in the past year.
- Typical check size: $20M – $150M.
Stage Focus
- Series B (43%)
- Series A (32%)
- Series Unknown (11%)
- Series C (7%)
- Seed (4%)
- Series E (4%)
Country Focus
- China (89%)
- United States (11%)
Industry Focus
- Manufacturing
- Biotechnology
- Pharmaceutical
- Electronics
- Semiconductor
- Health Care
- Service Industry
- Automotive
- Machinery Manufacturing
- Advanced Materials
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.